Who We Serve
Patients
Most readmissions to U.S. hospitals are caused by patients suffering from Chronic Obstructive Pulmonary Disease (COPD). And Congestive Heart Failure (CHF) is the leading diagnosis in U.S. hospitals today. Sanso Health is committed to helping these patients and others with chronic lung disease live longer and healthier through better oxygenation.
Clinicians
Our proprietary oxygen delivery and monitoring system helps clinicians monitor patients throughout the care continuum. This enables clinicians to optimize therapy by ensuring the right dose of oxygen is delivered to their patients when it is needed, reducing the potential for patients' being readmitted to the hospital during exacerbations.
Providers and Payers
Sanso helps patients live healthy and well through better oxygenation and as a result, increased physical activity. The Sanso Via has a unique and powerful capability to deliver the precise dose of oxygen to a patient dynamically (vs. static, continuous flow systems), resulting in a better-oxygenated patient. This directly improves a patient’s quality of life and, in turn, can significantly lower potential cost to providers and payers associated with hospital stays and reimbursement penalties from readmissions.
Most readmissions to U.S. hospitals are caused by patients suffering from Chronic Obstructive Pulmonary Disease (COPD). And Congestive Heart Failure (CHF) is the leading diagnosis in U.S. hospitals today. Sanso Health is committed to helping these patients and others with chronic lung disease live longer and healthier through better oxygenation.
Clinicians
Our proprietary oxygen delivery and monitoring system helps clinicians monitor patients throughout the care continuum. This enables clinicians to optimize therapy by ensuring the right dose of oxygen is delivered to their patients when it is needed, reducing the potential for patients' being readmitted to the hospital during exacerbations.
Providers and Payers
Sanso helps patients live healthy and well through better oxygenation and as a result, increased physical activity. The Sanso Via has a unique and powerful capability to deliver the precise dose of oxygen to a patient dynamically (vs. static, continuous flow systems), resulting in a better-oxygenated patient. This directly improves a patient’s quality of life and, in turn, can significantly lower potential cost to providers and payers associated with hospital stays and reimbursement penalties from readmissions.
Optimized DosingSanso technology helps improve the delivery and management of oxygen therapy by:
|
Peace of MindPatients can have improved quality of life once properly oxygenated and no longer have to choose to be less active in order to breath easier.
Family members can receive status updates from the system so they will know their loved one is using the system and can also monitor their progress along with healthcare provider. |